MMI Genomics, Inc., a wholly owned subsidiary of MetaMorphix®, Inc., was acquired from Celera Genomics in March of 2002.
MMI Genomics is a diagnostic company applying genomics and proteomics technologies to develop and commercialize innovative livestock and companion animal products that enhance animal health and productivity.